Search Results
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
Paolo Tarantino
Jul 8, 2024, 18:14 |
Insight
Paolo Tarantino: What is HER2 « ultralow » breast cancer, and why should you care?
Paolo Tarantino shared on X: “What is HER2 « ultralow » breast cancer, and why…
Jul 5, 2024, 06:54 |
Blog
Paolo Tarantino: Nearly 1000 downloads in less than a week for our ATEMPT 5-year publication
Paolo Tarantino, posted on X: "Nearly 1000 downloads in less than a week for our…
Jul 3, 2024, 08:52 |
Insight
Paolo Tarantino: More data supporting that ADCs act in part by extending the half life of payloads
Paolo Tarantino shared a post by Raffaele Colombo on X, adding the following: “More data…
Jul 3, 2024, 01:24 |
Blog
Paolo Tarantino: ATEMPT would have not been possible without the vision of Sara Tolaney
Sara Tolaney shared a post by Paolo Tarantino on X: “Very lucky to get to…
Jul 1, 2024, 18:24 |
Insight
Paolo Tarantino: How long should adjuvant T-DM1 be given for stage I HER2+ eBC?
Paolo Tarantino shared on X: "For how long should adjuvant T-DM1 be given for stage…
Jul 1, 2024, 15:23 |
Insight
Paolo Tarantino: Final analysis of the ATEMPT phase 2 trial
Paolo Tarantino shared a post on X: “Can ADCs help prevent recurrence from breast cancer…
Jun 26, 2024, 07:39 |
Insight
Paolo Tarantino discusses ASCO24 Breast Cancer highlights
Sameh AbdelMalak, Director of Oncology at Educational Partnerships at VuMedi, shared on X: "Check out…
Jun 26, 2024, 03:41 |
Insight
Paolo Tarantino: Opportunities to improve outcomes for early recurrent TNBC
Paolo Tarantino shared a post on X: . "Early recurrent TNBC (Triple-Negative…
Jun 26, 2024, 03:18 |
Insight
Paolo Tarantino: The 5 S rules help memorizing a simple framework to manage ILD
Paolo Tarantino shared on LinkedIn: “T-DXd is rapidly expanding in indications, from HER2+, to HER2-low, and…
Jun 25, 2024, 16:01 |
Insight
Paolo Tarantino: Phase 1 trial of the HER2 topo1 ADC SHR-A1811 out in Journal of Clinical Oncology
Paolo Tarantino shared on X: . "Phase 1 trial of the HER2 topo1 ADC SHR-A1811…
1
2
3
4
5
All:
196
Posts:
21 - 30
Paolo Tarantino: Top 10 Breast Cancer abstracts from ESMO2024
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 2
Running for a Cure: The Legacy of Terry Fox's Marathon of Hope
How The Breast Cancer Research Foundation was founded
Can Skin Cancer be Prevented by a $0.50 Soap? Meet TIME’s Kid of the Year and His Invention
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube